$650 Million in Pradaxa Settlements
Boehringer Ingelheim, the manufacturer of the drug Pradaxa, is settling 4,000 Pradaxa lawsuits for approximately $650 million. The Pradaxa settlements come even though Boheringer Ingelheim continues to assert that its own studies found the drug to be safe for use. The company’s stance on the matter is that it is better to pay out the settlements now than go through the legal process where a jury of people with no scientific background will be relied upon to interpret the complexities involved with the medication.
A spokesperson for Boheringer Ingelheim asserts that the Pradaxa settlements are a better choice than lengthy courtroom litigation and more negative exposure. An investigation by ABC News found that Pradaxa had the most number of complaints lodged with the FDA against it by Americans than any other medication in 2011 and 2012. Pradaxa is blamed for at least 1,158 deaths and 12,494 serious injuries in the United States. This information comes from the non-profit Institute for Safe Medicine Practices that monitors FDA reports.
Complications and Pradaxa Settlements
For many years, warfarin was the primary anticoagulant used for treatment in patients with a risk of stroke and conditions caused by blood clots. Even though it had been in use for a long time, warfarin still came with a number of risks. Warfarin and Pradaxa are both used to treat patients with atrial fibrillation so long as the patient is at risk for blood clots and stroke. Pradaxa not only outperformed warfarin in reducing strokes, but it was much easier to administer and required less doctor oversight.
Minor side effects are to be expected with any medication. The more serious side effects of Pradaxa include liver failure, hearth attack, uncontrolled bleeding, and death. Hemorrhages can easily cause death, while bleeding in the brain or directly affecting the central nervous system can create stroke-like results, which is exactly what the medication is supposed to prevent. Severe gastrointestinal bleeding was also a problem for some patients. Unlike warfarin, there is no quick shot to nullify the anticoagulant effects of Pradaxa.
Product liability suits were launched against Boehringer Ingelheim by patients as the side effects began to outweigh the benefits. Most notably, a study by the Cleveland Clinic and published in the Archives of Internal Medicine showed a 33% increased risk of heart attack and severe symptoms of heart disease compared to warfarin. Pradaxa was approved in 2010 by the FDA and touted as the replacement for warfarin. The drug grossed $1 billion in profits in 2011 alone. The product liability suits were eventually rolled into a MultiDistrict Litigation (MDL) that is now the focus of the Pradaxa settlements.
Seeking Legal Advice
If you or a loved one has experienced serious complications or death from taking Pradaxa, you may be entitled to compensation as part of the Pradaxa settlements. Contact the American Injury Attorney Group today for a free, no-obligation consultation. If you have a case and are eligible to be a part of the Pradaxa settlements, the American Injury Attorney Group can connect with you an affiliated attorney for representation.